Andersons pediatric cardiology 2120
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.56 KB, 3 trang )
affectthepharmacokineticand
pharmacodynamicresponsetoclopidogrelbut
notprasugrel.JThrombHaemost.
2007;5(12):2429–2436.
57.MegaJL,CloseSL,WiviottSD,etal.
Cytochromep-450polymorphismsandresponse
toclopidogrel.NEnglJMed.2009;360(4):354–
362.
58.MegaJL,SimonT,ColletJP,etal.ReducedfunctionCYP2C19genotypeandriskofadverse
clinicaloutcomesamongpatientstreatedwith
clopidogrelpredominantlyforPCI:ametaanalysis.JAMA.2010;304(16):1821–1830.
59.WesselDL,BergerF,LiJS,etal.Clopidogrelin
infantswithsystemic-to-pulmonary-artery
shunts.NEnglJMed.2013;368(25):2377–2384.
60.BaigentC,KeechA,KearneyPM,etal.Efficacy
andsafetyofcholesterol-loweringtreatment:
prospectivemeta-analysisofdatafrom90,056
participantsin14randomisedtrialsofstatins.
Lancet.2005;366(9493):1267–1278.
61.O'GormanCS,HigginsMF,O'NeillMB.
Systematicreviewandmetaanalysisofstatins
forheterozygousfamilialhypercholesterolemia
inchildren:evaluationofcholesterolchanges
andsideeffects.PediatrCardiol.
2009;30(4):482–489.
62.WagnerJ,Abdel-RahmanSM.Pediatricstatin
administration:navigatingafrontierwithlimited
data.JPediatrPharmacolTher.
2016;21(5):380–403.
63.MillsEJ,WuP,ChongG,etal.Efficacyand
safetyofstatintreatmentforcardiovascular
disease:anetworkmeta-analysisof170,255
patientsfrom76randomizedtrials.QJM.
2011;104(2):109–124.
64.TonelliM,LloydA,ClementF,etal.Efficacyof
statinsforprimarypreventioninpeopleatlow
cardiovascularrisk:ameta-analysis.CMAJ.
2011;183(16):E1189–E1202.
65.HedmanM,NeuvonenPJ,NeuvonenM,
AntikainenM.Pharmacokineticsand
pharmacodynamicsofpravastatininchildren
withfamilialhypercholesterolemia.Clin
PharmacolTher.2003;74(2):178–185.
66.HedmanM,NeuvonenPJ,NeuvonenM,
HolmbergC,AntikainenM.Pharmacokinetics
andpharmacodynamicsofpravastatinin
pediatricandadolescentcardiactransplant
recipientsonaregimenoftriple
immunosuppression.ClinPharmacolTher.
2004;75(1):101–109.
67.KnipscheerHC,BoelenCC,KasteleinJJ,etal.
Short-termefficacyandsafetyofpravastatinin
72childrenwithfamilialhypercholesterolemia.
PediatrRes.1996;39(5):867–871.
68.WiegmanA,HuttenBA,deGrootE,etal.
Efficacyandsafetyofstatintherapyinchildren
withfamilialhypercholesterolemia:a
randomizedcontrolledtrial.JAMA.
2004;292(3):331–337.
69.deJonghS,LilienMR,op'tRoodtJ,etal.Early
statintherapyrestoresendothelialfunctionin
childrenwithfamilialhypercholesterolemia.J
AmCollCardiol.2002;40(12):2117–2121.
70.deJonghS,OseL,SzamosiT,etal.Efficacyand
safetyofstatintherapyinchildrenwithfamilial
hypercholesterolemia:arandomized,doubleblind,placebo-controlledtrialwithsimvastatin.
Circulation.2002;106(17):2231–2237.
71.FerreiraWP,BertolamiMC,SantosSN,etal.
One-monththerapywithsimvastatinrestores
endothelialfunctioninhypercholesterolemic
childrenandadolescents.PediatrCardiol.
2007;28(1):8–13.
72.DirisamerA,HachemianN,BucekRA,etal.The
effectoflow-dosesimvastatininchildrenwith
familialhypercholesterolaemia:a1-year
observation.EurJPediatr.2003;162(6):421–
425.
73.StefanuttiC,LucaniG,VivenzioA,DiGiacomo
